The APGI is committed to providing broad access to its vast range of Biospecimens and Clinical Data. Our Cost Recovery Schedule has been reviewed and new charges are in place for 2017.
The APGI together with scientists around the country have mapped the genetic underpinnings of a rare type of Pancreatic Cancer.
Thank you for your continued partnership with the APGI. We appreciate your support and collaboration and hope you enjoy our 2016 research update…
Leaders in Pancreatic Cancer research and clinical care convened in Glasgow, Scotland for the annual Pancreas 2016 Meeting. The theme of the meeting was “Precision Medicine”….